IP Library Granted Patent US 8,951,274
Granted Patent B2
US 8,951,274 · App. 12/432,691 · Granted Feb 10, 2015

Methods of high rate, low profile tissue removal

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,951,274
App. No.
12/432,691
Granted
Feb 10, 2015
Kind
B2
Abstract

Disclosed are methods and devices for removing tissue from a site in a hollow organ, where the device has a low crossing profile and is capable of removing tissue at a high rate of speed. The device includes an elongate outer tube with a side opening and an inner tube moveably coaxially positioned within the outer tube. Tissue drawn into the side opening can be severed by moving the inner tube across the opening. Tissue may be removed through the device at a rate of at least about 1.4 cc per minute, through a lumen having a cross-sectional area of no greater than about 12.0 2 mm. Cutting may be accomplished by rotating the inner tube at a speed of at least about 4000 rpm, and axially reciprocating the inner tube at a rate of at least about 1.5 cycles per second. The window may have a rho value of no more than about 1, and the outside diameter of the device may be no more than about 3 mm.

Claims (38)

1. A method of removing tissue from a treatment site in a uterus, comprising the steps of:

accessing the uterus transcervically with an elongate tubular surgical device;

introducing fluid into the uterus;

applying a vacuum to remove fluid from the uterus through a lumen in the tubular surgical device;

severing tissue from the treatment site using the elongate tubular surgical device; and

removing the severed tissue from the treatment site through the lumen in the tubular surgical device at a removal rate of at least about 1.4 grams per minute,

wherein an outside diameter of a portion of the tubular surgical device accessing the uterus is no more than about 3 mm.

2. The method as in claim 1 , wherein the tissue is removed at a rate of at least about 1.5 grams per minute.

3. The method as in claim 1 , wherein the tissue is removed at a rate of at least about 1.8 grams per minute.

4. The method as in claim 1 , wherein the tissue is removed at a rate of at least about 2.0 grams per minute.

5. The method as in claim 1 , wherein the tissue comprises uterine fibroid tissue.

6. The method as in claim 1 , wherein the tissue is removed at a rate of at least about 2.2 grams per minute.

7. A method of removing tissue from a treatment site in a uterus, comprising the steps of:

distending the uterus;

transcervically introducing a tissue removal device into the uterus, wherein the tissue removal device comprises an elongate tubular device having an outer tube with a side opening and an inner tube coaxially positioned within the outer tube;

positioning the tissue removal device at the treatment site so that tissue extends into the side opening;

moving the inner tube with respect to the outer tube to sever tissue extending into the side opening; and

applying a vacuum to remove severed tissue through a lumen of the inner tube at a removal rate of at least about 1.5 grams per minute,

wherein the moving step comprises rotating the inner tube, while simultaneously causing the inner tube to oscillate translationally relative to the outer tube with an advance ratio of no more than about 0.25, the advance ratio being a ratio of the speed at which the inner tube oscillates translationally to the speed at which the inner tube rotates.

8. The method of removing tissue as in claim 7 , wherein the moving step comprises causing the inner tube to oscillate translationally at a rate of at least about 1.5 cycles per second.

9. The method of removing tissue as in claim 7 , wherein the side opening has a rho value of no more than about 1.

10. The method of removing tissue as in claim 9 , wherein the advance ratio is no more than about 0.15.

11. The method of removing tissue as in claim 9 , wherein the moving step comprises rotating the inner tube at a speed of at least 5000 rotations per minute.

12. The method of removing tissue as in claim 9 , wherein the moving step comprises rotating the inner tube at a speed of at least 6000 rotations per minute.

13. The method of removing tissue as in claim 9 , wherein the tissue removal device is introduced into the uterus through a lumen of an introducer sheath transcervically positioned in the uterus, a distal portion of the introducer sheath accessing the uterus having an outer diameter of about 5.5 mm.

14. The method as in claim 1 , wherein the tubular surgical device accesses the uterus through a lumen of an introducer sheath transcervically positioned in the uterus, a distal portion of the introducer sheath accessing the uterus having an outer diameter of about 5.5 mm.

15. The method as in claim 1 , wherein introducing the fluid into the uterus comprises introducing a quantity of fluid that is sufficient to distend the uterus.

16. The method of removing tissue as in claim 9 , wherein distending the uterus comprises introducing fluid into the uterus.

17. A method of removing tissue from a uterus, comprising:

distending the uterus;

transcervically introducing a tissue removal device into the uterus, the tissue removal device comprising an elongate tubular device having an outer tube with a side opening in a distal portion thereof, and an inner tube coaxially positioned within the outer tube;

positioning a distal portion of the tissue removal device at the treatment site so that tissue extends into the side opening of the outer tube;

moving the inner tube with respect to the outer tube to sever tissue extending into the side opening; and

applying a vacuum to remove severed tissue through a lumen of the inner tube at a removal rate of at least about 1.5 grams per minute,

wherein moving the inner tube with respect to the outer tube comprises rotating the inner tube at a speed of at least 5,000 rotations per minute, while simultaneously causing the inner tube to oscillate translationally relative to the outer tube at about 2.5 to 4 cycles per second.

18. The method of claim 17 , wherein the tissue removal device is introduced into the uterus through a lumen of an introducer sheath transcervically positioned in the uterus, a distal portion of the introducer sheath accessing the uterus having an outer diameter of about 5.5 mm.

19. The method of claim 17 , wherein the tissue comprises uterine fibroid tissue.

20. The method of claim 17 , wherein distending the uterus comprises introducing fluid into the uterus.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2011
From: INTERLACE MEDICAL, INC.
To: HOLOGIC, INC.
Reel/Frame 025835/0684 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 14, 2009
From: ADAMS, RONALD DAVID; CHIN, ALBERT CHUN-CHI; SULLIVAN, ROY HEWITT; LITSCHER, ERIC KARL; CHURCHILL, WILLIAM LUCAS; GRUBER, WILLIAM HARWICK
To: INTERLACE MEDICAL, INC.
Reel/Frame 022955/0700 →